Moreover, it has been reported that genes most frequently co-mutated with KRAS vary with the KRAS mutation alleles in patients with lung cancer, and these different patterns of co-mutation with KRAS differentially affect clinical outcomes33. This evidence concerns the gene KRAS and lung carcinoma.